The 2020 ISMRC Virtual Meeting is a great opportunity to gather researchers from academia and industry to share information about the most recent technical developments, clinical trials and late breaking news.
Due to the global COVID-19 outbreak, our participants and partners, as well as the organizing committee for the ISMRC2020 | Liquid Biopsy Conference, we have made appropriate adjustments to host online due to health and safety concerns. We will launch the online ISMRC2020 conference on Oct 24-25.
However,
to keep and share the new progress of knowledge, the 2020 ISMRC program will be
mostly moved to the online platform.
The 2020 virtual meeting is co-hosted together with the European Liquid Biopsy Society and Fudan University, co-organized by DIA (Drug Information Association) China and brings together basic and clinical researchers from academia and companies.
The 2020 ISMRC Virtual Meeting program will focus on LIQUID BIOPSY in a broader sense and will include presentations on Circulating Tumor Cells (CTCs) as well as circulating nucleic acids (DNA, miRNA) and exosomes, and clinical studies as well as the biology of metastasis, including cancer stemness, dormancy, epithelial-mesenchymal transition and imunomodulation of tumor cells, and more fields beyond cancer with emphasis on circulating fetal cells and single cell sequencing technologies.
Besides invited plenary talks by leading international experts, the 2020 ISMRC Virtual Meeting includes keynote live communications on Oct. 24-25 and on-demand presentations on Oct. 21-25 for registrants.
After great cities like Munich, Berlin, Oslo, San Francisco, Hamburg, Athens, Osaka, Paris & Montpellier, the next ISMRC/TLBC will take place virtually in October due to the COVID-19 pandemic. We hope that you will enjoy your time attending this 12th ISMRC/TLBC meeting and enjoy the opportunity to exchange information and establish long lasting collaborations with your colleagues.
We will be very happy to welcome you in October 2020 online!
| Main Topics
Liquid Biopsies in Cancer Immunotherapy
Early Detection of Cancer and MRD Detection
Liquid Biopsy-based Drug Target Detection and Discovering New Targets
Metastasis Biology
Technical Innovations in Liquid Biopsy and Single-Cell Sequencing